PAVM vs MSFT: Which Stock is Better?
Side-by-side comparison of Pavmed Inc and Microsoft Corp in 2026
PAVM
Pavmed Inc
$9.12
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | PAVM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $57.53M | N/A | PAVM |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 4.2% | 0.2% | PAVM |
| Gross Margin | -207.0% | 68.6% | MSFT |
Analyze PAVM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PAVM or MSFT a better investment?
Comparing PAVM and MSFT: Pavmed Inc has a market cap of $57.53M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PAVM and MSFT?
PAVM (Pavmed Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PAVM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PAVM or MSFT?
PAVM has higher revenue growth at 4.2% vs 0.2% for MSFT.
Which company is more profitable: PAVM or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -207.0% for PAVM.
Which is the larger company: PAVM or MSFT?
Pavmed Inc (PAVM) is larger with a market cap of $57.53M compared to N/A for MSFT.
Should I buy PAVM or MSFT in 2026?
Both PAVM and MSFT have investment merit. PAVM trades at $9.12 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PAVM and MSFT stock?
Key differences: Market Cap ($57.53M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (4.2% vs 0.2%), Gross Margin (-207.0% vs 68.6%).